
FDA approves Gilead HIV prevention injection lenacapavir
The Food and Drug Administration on Wednesday approved Gilead’s twice-yearly antiviral injection for preventing HIV – a milestone that the company and some experts say could help bring the world closer to ending the decades-long epidemic caused by the virus. But the launch of the injectable drug, which will be marketed under the name Yeztugo,…